Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.440
+0.140 (4.33%)
Dec 30, 2024, 11:48 AM EST - Market open
Cyclerion Therapeutics Market Cap
Cyclerion Therapeutics has a market cap or net worth of $8.68 million as of December 30, 2024. Its market cap has increased by 65.04% in one year.
Market Cap
8.68M
Enterprise Value
5.48M
1-Year Change
65.04%
Ranking
Category
Stock Price
$3.43
Market Cap Chart
Since March 18, 2019, Cyclerion Therapeutics's market cap has decreased from $193.31M to $8.68M, a decrease of -95.51%. That is a compound annual growth rate of -41.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 27, 2024 | 8.35M | 1.96% |
| Dec 29, 2023 | 8.19M | -71.30% |
| Dec 30, 2022 | 28.54M | -61.69% |
| Dec 31, 2021 | 74.50M | -28.31% |
| Dec 31, 2020 | 103.92M | 39.09% |
| Dec 31, 2019 | 74.72M | -61.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 705.19B |
| UnitedHealth Group | 469.34B |
| Novo Nordisk | 393.39B |
| Johnson & Johnson | 349.23B |
| AbbVie | 314.57B |
| Merck & Co. | 252.20B |
| AstraZeneca | 204.17B |
| Thermo Fisher Scientific | 201.22B |